Kits Eyecare Ltd banner

Intrinsic Value

The intrinsic value of Kits Eyecare Ltd (0P3) under the Base Case is 7.35 EUR per share. Compared with the current market price of 11.6 EUR, the stock appears Overvalued by 37% .

The intrinsic value is the average of valuations using the DCF method and multiples.

Do our valuations actually work? See backtest results .

0P3 Intrinsic Value
€7.35
Overvaluation 37%
Intrinsic Value
Price €11.6
Alert me when 0P3 is below its intrinsic value
Today €5.88 · 49.3% below the current price

We don’t have enough historical valuation data to make this comparison.

Alternatives to 0P3

Fundamental Analysis

What Kits Eyecare Does

Retail Consumer Discretionary

Kits Eyecare Ltd sells eyeglasses, contact lenses, and related eye-care products directly to consumers, mainly through its online store. Customers upload or update their prescriptions, choose frames or lenses, and the company handles order processing, lens fitting, and delivery. Its core buyers are people who need vision correction and want to shop for eyewear without visiting a traditional optical shop.

Headquarters
Canada CA
Employees
176
IPO date
Jan 19, 2021
Read the full company overview
View Company Overview
Financials

Balance Sheet

Efficiency

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Recent Events

Latest Earnings Call

Q3 2026 · November 5, 2026

Kits paired accelerating growth with margin expansion, as repeat customers and a growing glasses business reinforced its customer-led model.

What management delivered: 2 within the range

Open the earnings call
EPS
CA$0.02
Expected
CA$0.06
Surprise
−66.7%
Stock, next trading day
+0.4%
View Earnings Call

Past 12 months

Continue 0P3 Research

Decided on Kits Eyecare? Get an email when 0P3 reaches the price you’d buy at. Free with an account.

Other Kits Eyecare listings

What is the Intrinsic Value of one 0P3 stock?

The intrinsic value for Kits Eyecare Ltd (0P3) under the Base Case is 7.35 EUR.

Is 0P3 stock undervalued or overvalued?

Compared with the current market price of 11.6 EUR, the stock appears Overvalued by 37% .

How reliable are our estimates? See how past valuations played out
Back to Top